Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The term skeletal and cardiac muscle cell nuclear episomal machinery refers to the collective cellular processes and structural components within the nuclei of myocytes and cardiomyocytes that support the persistence and transcription of extrachromosomal DNA (episomes). In the context of gene therapy, particularly using Adeno-Associated Virus (AAV) vectors, the delivered genetic material typically does not integrate into the host genome but instead forms circularized, stable episomal concatemers. These episomes rely on the host's nuclear machinery for long-term maintenance and expression, which is particularly effective in post-mitotic tissues like skeletal and cardiac muscle where cell division is minimal. While this machinery is critical for the success of non-integrating gene therapies, it is not a single therapeutic target (such as a receptor or enzyme) but rather a biological environment or system utilized by genetic medicines to treat disorders like Duchenne muscular dystrophy or certain cardiomyopathies.
Not applicable as this is a cellular system/location rather than a specific drug target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Skeletal and cardiac muscle cell nuclear episomal machinery.